Swiss stocks - Factors to watch on June 29
ZURICH, June 29 The Swiss blue-chip SMI was seen opening 0.4 percent higher at 9,110 points on Thursday, according to premarket indications by bank Julius Baer .
April 17 Oncomed Pharmaceuticals Inc
* Oncomed's Phase 2 trial of Tarextumab in small cell lung cancer does not meet endpoints
* Oncomed Pharmaceuticals Inc - trial did not meet its primary endpoint of progression-free survival or secondary endpoints
* Also announces discontinuation of brontictuzumab Phase 1B study Source text for Eikon: Further company coverage:
* Graphic of LNG exports by country: http://tmsnrt.rs/2sohd8u